91.9%
ICBMelanomanon-small-cell lung cancerStanford University
…7 and 38, which is reflective of this patient‘s non-response to ICB therapyAbstract 103 Figure 2Mapping of PD1/PD-L1 interactions T…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 541–600 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
N-Acetyl Cysteine7PPIs7Streptozotocin7fondaparinux7high-dose corticosteroids7hydroxyurea7naltrexone7tyrosine kinase inhibitors7vaccines7SGLT-2i6Glipizide6BLV6Varenicline6Camrelizumab6Cancer Drugs6Benzene6Doxy-PEP6SGLT-2is6Aprepitant6DEX6Dostarlimab6T-DXd6Azacitidine6Esketamine6NAC6Fidaxomicin6ITM6Minocycline6N-acetylcysteine6pMDIs6NBCA6Clofazimine6Filgotinib6Ravulizumab6Atomoxetine6Methylphenidate6amoxicillin-clavulanate6Acetylcysteine6Triamcinolone6anti-PD16Nitrous oxide6Octreotide6injectate6IL-1β6Lenalidomide6OAC6Venetoclax6antihypertensive drugs6n-BCA6Anti-TNF6Golimumab6Placebo6aripiprazole6b/tsDMARDs6Lansoprazole6MDPV6Mitomycin C6Nalbuphine6PCSK9 inhibitors6Sodium-Glucose Co-Transporter 2 Inhibitors6
Articles mentioning drugs
10,506 articles · page 564 of 876corticosteroidscytokine inhibitorscanceradvanced malignanciestumor
…tments often consist of broad immunosuppressive agents, such as corticosteroids and cytokine inhibitors, which have been shown to potentially d…
82.0%
DMSOmonoclonal antibodiesMycoplasma contamination
…luding those with high cell density and cryoprotectants such as DMSO.…
ICIsImmune checkpoint inhibitorsstage III melanomaJAMA OncolJAMA Network Open
…Background Immune checkpoint inhibitors (ICIs) have transformed the management of stage III melanoma, offerin…
ipilimumabnivolumabmelanomamelanoma-specifictertiary care center
…, Wai ES, et al. Survival outcomes following discontinuation of ipilimumab and nivolumab for advanced melanoma in a population-based cohor…
immune checkpoint inhibitorsmelanomaHodgkin lymphomanon-small cell lung cancerhepatocellular carcinomahead and neck squamous cell carcinomarenal cell carcinomaRCC
… Salem JE, Cohen JV, et al. Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis. JAMA Oncol. 2018;4(12):…
infliximabrituximabmyasthenia gravismyocarditismyositisir-myocarditisir-myositis
…ICT clearance), rituximab (anti-CD20 for B-cell depletion), and infliximab (anti-TNF-a for T-cell and potential myeloid suppression). We h…
ICIimmune checkpoint inhibitorJohns Hopkins HospitalJHHOncology Evaluation and Treatment Center
… use was conducted, identifying 737 patients actively receiving ICI therapy and 67 active irAE encounters. Root cause analysis, inc…
pembrolizumabnivolumabNSCLCnon-small cell lung cancerCohort 1Cohort 2TriNetX Global Collaborative NetworkSLERApsoriasis+1 more
…cluded patients who received at least one ICI (e.g., nivolumab, pembrolizumab); Cohort 2 included those who did not. Propensity score matchin…
NACbreast cancerBCHER2-negative BCTNBC
…on from three cohorts of HER2-negative BC patients treated with NAC, validating model generalizability. We systematically assessed …
immune checkpoint inhibitorsICIsnon-small cell lung cancerneoadjuvant chemotherapyTianjin Medical University Cancer Institute and HospitalNSCLC
…SCLC) patients receiving neoadjuvant chemotherapy combined with immune checkpoint inhibitors (ICIs).Methods Cases meeting inclusion criteria were divided in…
PD-L1 ICIsimmune checkpoint inhibitors (ICIs)Providence Health SystemWest Cancer Centermetastatic melanomaaNSCLCES-SCLCEuropean Unionadvanced non-small cell lung cancerkidney cancer+3 more
…l CTRS to 243 patients with advanced-stage cancers treated with PD-L1 ICIs at Providence Health System and West Cancer Center, including 8…